- Molecular Assay Technologies (PCR-Based Molecular Assays
- Sequencing-based Molecular Assays
- Non-molecular Assay Technologies
Transplant Diagnostics Market size was valued at USD 4.1 billion in 2022 and is poised to grow at a CAGR of 7.8% from 2022 to 2029. One of the main factors driving the expansion of the market under study is the increase in organ donation. In January 2021, more than 12,500 people donated one or more organs in 2020, up 6% from the year before, according to figures released by the Association of Organ Procurement Organizations (AOPO). Over 36,500 organs were donated from deceased donors in 2020, an increase of nearly 2% compared to the previous year. For the seventh consecutive year, these recovered organs saved more lives more than 33,000 than they did the year before. Donation after Circulatory Death (DCD) contributions also saw significant increases; they totalled more than 3,000 donors, an 18% rise from the previous year. Increased transplant diagnostic testing will result from increased organ donation, propelling market expansion. The diagnosis of pulmonary function and general health is emphasized much in the context of heart transplants. The diagnostics have considerably improved over the last ten years due to businesses dedicated themselves to creating better HLA typing technologies, antibody monitoring, equipment, and software. This is rapidly employed for diagnostic purposes during organ transplantation across various body parts. Multispecialty hospitals in developed markets are doing many more transplant procedures due to technical developments and expanding financial opportunities made possible by public-private partnerships. To assess the level of infection inside an organ, the diagnosis for transplantation is carried out at the donor and patient's ends. Additionally, several significant players are releasing new products on the market, which is anticipated to further fuel market expansion. For instance, in September 2021, Thermo Fisher Scientific added two new products to its range of transplant diagnostics during the American Society for Histocompatibility and Immunogenetics (ASHI) annual meeting.
Study Period
2024-2030Base Year
2023CAGR
7.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
A significant aspect driving demand for diagnostics before the surgery is the rise in organ transplants. There has always been a greater need for transplants than there are available organs. However, the market will likely profit from in-depth field studies and analyses to close this gap. An increase in the number of people with chronic illnesses that frequently cause organ failure is driving the rising demand for transplant surgeries. Personalized medicine and stem cell therapy are also becoming more popular, increasing the demand for transplant diagnostics. Improved and sophisticated diagnostic methods are required due to the risks and complexity of organ transplantation. Due to an increasing need for high-throughput diagnostic tools with improved accuracy, Next-Generation Sequencing (NGS) technology is quickly replacing traditional diagnostic approaches, such as serological techniques used in Human Leukocyte Antigen (HLA) type. However, the scarcity of available organs for transplant procedures, difficulties with HLA sequencing, and general ignorance restrain market expansion.
By Technology
By Product Type
By Transplant
By Application
By End User
The transplant diagnostics market is projected to expand at a CAGR of 7.8% during the forecast period.
Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences
North America is the fastest-growing region for transplant diagnostics market
1. Executive Summary |
2. Global Transplant Diagnostics Market Introduction |
2.1.Global Transplant Diagnostics Market - Taxonomy |
2.2.Global Transplant Diagnostics Market - Definitions |
2.2.1.Technology |
2.2.2.Product Type |
2.2.3.Transplant |
2.2.4.Application |
2.2.5.End User |
3. Global Transplant Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Transplant Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Transplant Diagnostics Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Molecular Assay Technologies (PCR-Based Molecular Assays |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Sequencing-based Molecular Assays |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Non-molecular Assay Technologies |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Transplant Diagnostics Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Reagents & Consumables |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Instruments |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Software & Services |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Transplant Diagnostics Market By Transplant, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Solid Organ Transplantation |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Stem Cell Transplantation |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Soft Tissue Transplantation |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Bone marrow Transplantation |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Transplant Diagnostics Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Diagnostic Applications |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Diagnostics |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Research Applications |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9. Global Transplant Diagnostics Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Independent Reference Laboratories |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Hospitals & Transplant Centers |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Research Laboratories & Academic Institutes |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
10. Independent Reference Laboratories Transplant Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Molecular Assay Technologies (PCR-Based Molecular Assays |
10.1.2.Sequencing-based Molecular Assays |
10.1.3.Non-molecular Assay Technologies |
10.2. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Reagents & Consumables |
10.2.2.Instruments |
10.2.3.Software & Services |
10.3. Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Solid Organ Transplantation |
10.3.2.Stem Cell Transplantation |
10.3.3.Soft Tissue Transplantation |
10.3.4.Bone marrow Transplantation |
10.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Diagnostic Applications |
10.4.2.Diagnostics |
10.4.3.Research Applications |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Hospitals & Transplant Centers Transplant Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Molecular Assay Technologies (PCR-Based Molecular Assays |
11.1.2.Sequencing-based Molecular Assays |
11.1.3.Non-molecular Assay Technologies |
11.2. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Reagents & Consumables |
11.2.2.Instruments |
11.2.3.Software & Services |
11.3. Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Solid Organ Transplantation |
11.3.2.Stem Cell Transplantation |
11.3.3.Soft Tissue Transplantation |
11.3.4.Bone marrow Transplantation |
11.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Diagnostic Applications |
11.4.2.Diagnostics |
11.4.3.Research Applications |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Research Laboratories & Academic Institutes Transplant Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Molecular Assay Technologies (PCR-Based Molecular Assays |
12.1.2.Sequencing-based Molecular Assays |
12.1.3.Non-molecular Assay Technologies |
12.2. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Reagents & Consumables |
12.2.2.Instruments |
12.2.3.Software & Services |
12.3. Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Solid Organ Transplantation |
12.3.2.Stem Cell Transplantation |
12.3.3.Soft Tissue Transplantation |
12.3.4.Bone marrow Transplantation |
12.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Diagnostic Applications |
12.4.2.Diagnostics |
12.4.3.Research Applications |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.2. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Reagents & Consumables |
13.2.2.Instruments |
13.2.3.Software & Services |
13.3. Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Solid Organ Transplantation |
13.3.2.Stem Cell Transplantation |
13.3.3.Soft Tissue Transplantation |
13.3.4.Bone marrow Transplantation |
13.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Diagnostic Applications |
13.4.2.Diagnostics |
13.4.3.Research Applications |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.2. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Reagents & Consumables |
14.2.2.Instruments |
14.2.3.Software & Services |
14.3. Transplant Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Solid Organ Transplantation |
14.3.2.Stem Cell Transplantation |
14.3.3.Soft Tissue Transplantation |
14.3.4.Bone marrow Transplantation |
14.4. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Diagnostic Applications |
14.4.2.Diagnostics |
14.4.3.Research Applications |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.LXN Corporation |
15.2.2.Horiba Medical |
15.2.3.Alpha Laboratories |
15.2.4.Cylex Inc |
15.2.5.Otsuka Holdings Co Ltd |
15.2.6.Laboratory Corporation of America Holdings |
16. Research Methodology |
17. Appendix and Abbreviations |